Anti-LPA1 antibody
Specifications
| Product Cat#: | AB-06-2730 |
| Product type: | Primary antibody |
| Antigen: | LPA1 |
| Immunogen: | KLH conjugated synthetic peptide derived from human EDG2/LPA1 281-364/364 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2000) |
| Reactivity: | Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Sheep |
| Clonality (clone number): | Polyclonal |
| Buffer: | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| Alternative names: | EDG 2 |
| Endothelial Cell Differentiation Gene-2 | |
| Endothelial differentiation gene 2 | |
| Endothelial Differentiation Lysophosphatidic Acid G Protein Coupled Receptor 2 | |
| G10 protein homolog | |
| GPCR 26 | |
| GPCR26 | |
| Gpcr91 | |
| Kdt2 | |
| LPA 1 | |
| LPA receptor 1 | |
| LPA receptor EDG2 | |
| LPA1 | |
| LPAR1 | |
| Lysophosphatidic acid receptor 1 | |
| Lysophosphatidic acid receptor EDG2 | |
| MGC105279 |
Show More
Target information
Receptor for lysophosphatidic acid (LPA) (PubMed:9070858, PubMed:19306925, PubMed:25025571, PubMed:26091040). Plays a role in the reorganization of the actin cytoskeleton, cell migration, differentiation and proliferation, and thereby contributes to the responses to tissue damage and infectious agents. Activates downstream signaling cascades via the G(i)/G(o), G(12)/G(13), and G(q) families of heteromeric G proteins.
Provider
Erpantech Laboratory
